This trial is active, not recruiting.

Condition depression
Treatment icbt for late life depression
Sponsor Northwestern University
Start date December 2015
End date October 2016
Trial size 50 participants
Trial identifier NCT02841787, P20MH090318-FT


The goal of this field trial is to tailor and test a web-based intervention in adults 65 years of age or older. Two versions of the web-based intervention have been created and will be tested--one with an online social network and one without an online social network. The purpose of this study is to: pilot a novel intervention, examine methods to improve adherence to web-based interventions (e.g., peer network); collect data on feasibility, acceptability, and efficacy of an web-based intervention for late life depression; and ultimately, to overcome the numerous barriers to treating depression in later life.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation non-randomized
Intervention model parallel assignment
Masking open label
Primary purpose treatment
iCBT for late life depression with social network included
icbt for late life depression
iCBT for late life depression without social network included
icbt for late life depression
(No Intervention)
Waiting period, no intervention administered. Receive iCBT for late life depression after waiting period.

Primary Outcomes

time frame: Baseline to end of treatment (8 weeks)
Adherence to the program
time frame: Baseline to end of treatment (8 weeks)

Eligibility Criteria

Male or female participants at least 65 years old.

Inclusion Criteria: - Has elevated depressive symptoms - Has a telephone, e-mail account, computer, and broadband access to the Internet. - Has basic internet skills and is able to access the internet independently - Is able to speak and read English. - Is at least 65 years of age. - Is able to give informed consent. Exclusion Criteria: - Has hearing or voice impairment that would prevent participation in psychotherapy - Has visual impairment that would prevent completion of assessment materials. - Is diagnosed with a psychotic disorder, bipolar disorder, dissociative disorder, current substance abuse, or other diagnosis for which participation in a clinical trial of psychotherapy may be either inappropriate or dangerous. - Is currently receiving individual psychotherapy or planning to receive psychotherapy during the 8-week treatment phase of the study - Is planning to be out of town or unavailable for an extended period of time during the study without access to the Internet - Exhibits severe suicidality, including ideation, plan, and intent. - Has initiated treatment with an antidepressant in past 14 days. Once patients have been on a stable dose for 14 days and do not have an appointment with a physician or psychiatrist to change this dose, the patient will be eligible based on this criterion.

Additional Information

Official title Technology Assisted Intervention for the Treatment and Prevention of Depression
Principal investigator David C Mohr, PhD
Trial information was received from ClinicalTrials.gov and was last updated in July 2016.
Information provided to ClinicalTrials.gov by Northwestern University.